ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,766Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 2094

$2.11M Total Retail Price of All Prescriptions

Rank: 12 out of 2094

300 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 15,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

58% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$113 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
CRESTOR 609 541 1 15
NEXIUM 563 472 2 16
LOVAZA 458 403 3 53
LIDODERM 456 411 4 59
ZOLPIDEM TARTRATE 397 320 5 14
METOPROLOL SUCCINATE 341 296 6 9
DONEPEZIL HCL 324 304 7 20
DIOVAN 318 287 8 13
LEVOTHYROXINE SODIUM 272 225 9 3
OMEPRAZOLE 256 201 10 4
VOLTAREN 254 227 11 109
GABAPENTIN 250 193 12 23
FUROSEMIDE 250 219 12 6
ATORVASTATIN CALCIUM 238 199 14 5
MECLIZINE HCL 236 198 15 103
AMLODIPINE BESYLATE 234 216 16 2
CELEBREX 231 216 17 74
LYRICA 218 189 18 85
DIOVAN HCT 215 192 19 28
PLAVIX 208 193 20 38
JANUVIA 204 198 21 35
IBANDRONATE SODIUM 201 169 22 140
SINGULAIR 195 170 23 64
SPIRIVA 194 147 24 60
CLOPIDOGREL 192 158 25 22
CARVEDILOL 189 175 26 19
NAMENDA 184 180 27 32
POLYETHYLENE GLYCOL 3350 179 166 28 75
SIMVASTATIN 165 128 29 1
SOLARAZE 159 121 30 278
LANTUS SOLOSTAR 150 124 31 76
BENICAR 149 136 32 108
HYDROCHLOROTHIAZIDE 148 122 33 12
MELOXICAM 146 130 34 49
CLOTRIMAZOLE-BETAMETHASONE 138 115 35 91
ESCITALOPRAM OXALATE 133 104 36 46
PATADAY 133 113 36 376
AMITIZA 132 121 38 239
ADVAIR DISKUS 128 85 39 36
TAMSULOSIN HCL 124 113 40 29
FLUTICASONE PROPIONATE 122 92 41 41
BYSTOLIC 118 114 42 83
AMMONIUM LACTATE 116 99 43 185
FEXOFENADINE HCL 115 91 44 191
WELCHOL 115 85 44 146
ALENDRONATE SODIUM 114 113 46 30
MONTELUKAST SODIUM 113 94 47 128
LISINOPRIL 113 90 47 7
PENNSAID 112 85 49 421
ACTONEL 112 112 49 151
PROAIR HFA 111 85 51 45
ZETIA 110 86 52 79
TRICOR 109 92 53 99
DEXILANT 104 98 54 124
AMLODIPINE BESYLATE-BENAZEPRIL 103 78 55 58
CHLORHEXIDINE GLUCONATE 103 95 55 319
HYDRALAZINE HCL 100 88 57 89
POTASSIUM CHLORIDE 100 82 57 24
LACTULOSE 99 89 59 65
METFORMIN HCL 95 94 60 8
ARICEPT 88 88 61 386
SYNTHROID 86 85 62 44
AVODART 86 86 62 163
ENALAPRIL MALEATE 85 71 64 25
MICARDIS HCT 83 83 65 266
LABETALOL HCL 83 76 65 215
BACLOFEN 82 54 67 166
PAROXETINE HCL 82 78 67 77
ONGLYZA 81 81 69 134
TRAMADOL HCL-ACETAMINOPHEN 80 48 70 100
NASONEX 80 70 70 194
MOMETASONE FUROATE 76 67 72 229
PANTOPRAZOLE SODIUM 75 64 73 37
BENICAR HCT 74 67 74 133
CREON 74 64 74 219
ADVAIR HFA 73 69 76 382
AZITHROMYCIN 71 55 77 27
VYTORIN 68 67 78 162
LUNESTA 67 65 79 293
BYETTA 66 57 80 369
DULERA 65 54 81 349
NAPROXEN 65 41 81 84
LOSARTAN POTASSIUM 64 52 83 17
TRIBENZOR 64 64 83 264
PEN NEEDLE 64 46 83 136
LEXAPRO 64 57 83 180
CYMBALTA 63 51 87 61
LANTUS 63 39 87 66
VICTOZA 2-PAK 62 40 89 393
CLONIDINE HCL 62 56 89 62
ENDOCET 61 30 S2 91 88
TRILIPIX 61 55 91 156
SERTRALINE HCL 60 40 93 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 36 94 55
BONIVA 58 49 95 256
WARFARIN SODIUM 55 48 96 11
NOVOLOG FLEXPEN 54 43 97 142
VENTOLIN HFA 54 52 97 132
CYCLOBENZAPRINE HCL 53 42 R 99 115
LIPITOR 53 37 99 39
EXELON 52 42 101 111
GLIPIZIDE 51 46 102 82
TRAMADOL HCL 50 50 103 33
NIFEDIPINE ER 50 50 103 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.